Training Papers

Despite growing use, peripherally inserted central catheters (PICCs) are associated with risk of deep vein thrombosis (DVT). We designed a study to determine patient, provider and device factors associated with this outcome. Read more here

The importance of decontaminating needleless connectors prior to accessing central venous access devices (CVADs) to prevent CVAD-associated bloodstream infection has been highlighted. However, the optimal decontamination time and solution is still under-evaluated. This study will compare different decontamination methods of CVAD needleless connectors in adult patients. The aims of this pilot trial are: to assess

Essential across clinical specialties, around 2 billion peripheral venous catheters (PVCs) are sold annually worldwide.1 As a foreign body, PVCs frequently cause phlebitis, and this inflammation is perhaps also the mechanism underlying other common complications of occlusion, infiltration, and even dislodgement. Read more here

Researchers have carried out a study to evaluate parameters that influence the amount of movement of peripherally inserted central catheter (PICC) tips regarding upper limb movement. Read more here

The purpose of this study is to evaluate feasibility of an efficacy trial comparing peripherally inserted central catheter (PICC) dressing and securement techniques to prevent complications and failure. This pilot, 3-armed, randomized controlled trial was undertaken at Royal Children’s Hospital and Lady Cilento Children’s Hospital, Brisbane, Australia, between April 2014 and September 2015. This article

Researchers have developed a new tool for identifying the composition of arterial plaque most likely to rupture and cause a heart attack. The catheter probe combines intravascular ultrasound with fluorescence imaging to image the tiny arteries of a living heart. The new catheter can simultaneously retrieve structural and chemical information about arterial plaque,  which could

A research team of Toho University and Tokyo Institute of Technology has developed a mechanism of a self-propelled catheter capable of generating peristaltic motion just like an earthworm by applying pneumatic pressure inside only one tube. The goal is to develop an AutoGuide robot that propels itself inside bronchi, automatically reaching the target lesion within

Catheter to vessel ratio (CVR) may be defined as the: “indwelling space or area consumed or occupied by an intravascular device inserted and positioned within a venous or arterial blood vessel.” The CVR is an extremely important assessment factor for all vascular access specialists and like-minded clinicians placing intravascular devices. Read more here

TORONTO, ONTARIO-(Marketwired – Sept. 26, 2017) – Interface Biologics Inc. (“IBI”), a privately held, commercial stage company developing innovative material science technologies that save lives and improve patient outcomes, is pleased to announce that Arkis BioSciences® has received 510(k) clearance from U.S. Food and Drug Administration (FDA) for its exclusive CerebroFlo™ EVD Catheter with IBI’s Endexo®

Two preliminary studies were conducted to determine feasibility of using the electrocardiography (EKG) method to determine terminal tip location when inserting a peripherally inserted central catheter (PICC). This method uses the guide-wire inside the catheter (or a column of saline contained in the catheter) as an intracavitary electrode. The EKG monitor is then connected to